Company profile for Second Genome

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Second Genome is at the cutting edge of microbiome science, translating breakthrough research into medicines and other novel products that help humanity. Our scientists and staff are true pioneers in this dynamic field. We are advancing a pipeline of novel therapies for serious diseases, while also making new breakthroughs in multiple fields of research using our one-of-a kind discovery platform. With our impact felt acros...
Second Genome is at the cutting edge of microbiome science, translating breakthrough research into medicines and other novel products that help humanity. Our scientists and staff are true pioneers in this dynamic field. We are advancing a pipeline of novel therapies for serious diseases, while also making new breakthroughs in multiple fields of research using our one-of-a kind discovery platform. With our impact felt across industries — from healthcare and nutrition to agriculture — we are recognized as global leaders in translating rapidly emerging science into products that help humanity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
341 Allerton Avenue, South San Francisco, CA 94080
Telephone
Telephone
(650) 440-4606
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/second-genome-presents-new-data-at-digestive-disease-week-ddw-2022-demonstrating-that-sg-5-00455-a-potential-first-in-class-precision-therapeutic-improves-epithelial-barrier-function-and-promotes-mucosal-healing-in-inflammator-301553343.html

PRNEWSWIRE
24 May 2022

https://www.prnewswire.com/news-releases/second-genome-presents-new-preclinical-data-at-aacr-2022-demonstrating-that-sg-3-06686-a-cxcr3-chemokine-receptor-modulator-induces-migration-of-immune-effector-cells-inhibits-tumor-growth-as-monotherapy-and-boosts-anti-program-301520919.html

PRNEWSWIRE
08 Apr 2022

https://www.prnewswire.com/news-releases/second-genome-announces-bayer-exercised-option-following-completion-of-multi-year-collaboration-301493416.html

PRNEWSWIRE
02 Mar 2022

https://www.prnewswire.com/news-releases/second-genome-virtual-kol-event-highlighted-critical-role-of-mucosal-healing-and-pai-12-in-inflammatory-bowel-disease-ibd-301489293.html

PRNEWSWIRE
24 Feb 2022

https://www.prnewswire.com/news-releases/second-genome-presents-preclinical-data-at-crohns--colitis-foundations-ibd-innovate-conference-for-potential-first-in-class-mucosal-healing-therapeutic-sg-5-00455-301428692.html

PRNEWSWIRE
18 Nov 2021

https://www.prnewswire.com/news-releases/second-genome-presents-preclinical-data-highlighting-potential-therapeutic-implications-of-altered-gut-microbiome-and-metabolites-in-autism-spectrum-disorder-model-and-parkinsons-disease-at-the-society-for-neuroscience-annual-mee-301421811.html

PRNEWSWIRE
11 Nov 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty